TOKYO -- Stocks of midsize Japanese pharmaceutical companies have become beneficiaries of market expectations over "Suganomics," Prime Minister Yoshihide Suga's policy initiatives.
Markets
'Suganomics' puts spotlight on potential of fertility drug makers
Japan PM's initiative to subsidize treatments helps pharmaceutical stocks surge
Prime Minister Yoshihide Suga's support for women trying to have babies could drive market growth for obstetric and gynecological drugs. (Photo by Uichiro Kasai)
Read Next
Latest on Markets
